Postpartum Hemorrhage in Women with Von Willebrand Disease - A Retrospective Observational Study
- PMID:27780267
- PMCID: PMC5079555
- DOI: 10.1371/journal.pone.0164683
Postpartum Hemorrhage in Women with Von Willebrand Disease - A Retrospective Observational Study
Erratum in
- Correction: Postpartum Hemorrhage in Women with Von Willebrand Disease - A Retrospective Observational Study.Govorov I, Löfgren S, Chaireti R, Holmström M, Bremme K, Mints M.Govorov I, et al.PLoS One. 2017 Feb 9;12(2):e0172185. doi: 10.1371/journal.pone.0172185. eCollection 2017.PLoS One. 2017.PMID:28182756Free PMC article.
Abstract
Introduction: von Willebrand disease (VWD) is a hereditary bleeding disorder, caused by a deficiency in the levels and/or function of von Willebrand factor (VWF). Women with VWD appear to be at increased risk of experiencing postpartum hemorrhage (PPH), though the levels of VWF increase during pregnancy. There is limited knowledge of how PPH is associated with the subtype of VWD, plasma levels of other coagulations factors than VWF and given hemostatic treatment.
Aims: The aims were to investigate the incidence of PPH in women with VWD and to analyse the correlation between PPH and: (1) type of VWD, (2) laboratory monitoring of VWF and FVIII and (3) hemostatic drug treatment.
Methods: This was a retrospective observational study. The study participants (n = 34) were recruited from the Coagulation Unit, Karolinska University hospital. Fifty-nine deliveries, which occurred in 14 different obstetrics units (years 1995-2012) were included in the study.
Results: The incidence of primary PPH was 44%, severe primary PPH 20% and secondary PPH 12%. VWD type 3 was associated with a higher risk of experiencing severe primary PPH compared to other subtypes. FVIII:C in pregnancy was inversely correlated to blood loss during delivery. There was a significantly higher incidence of secondary PPH when the VWD diagnosis was unknown at time of delivery.
Conclusions: The women with VWD are at higher risk of PPH, especially those with type 3 VWD or when diagnosis is unknown prior to delivery. Identification of pregnant women with undiagnosed VWD may be of importance in order to prevent PPH.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




Similar articles
- Postpartum Hemorrhage in Women with von Willebrand Disease: Consider Other Etiologies.Kazi S, Arusi I, McLeod A, Malinowski AK, Shehata N.Kazi S, et al.J Obstet Gynaecol Can. 2022 Sep;44(9):972-977. doi: 10.1016/j.jogc.2022.03.017. Epub 2022 May 13.J Obstet Gynaecol Can. 2022.PMID:35569789
- Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: Outcomes at a single-institution cohort study.Lim MY, Rodgers GM, Branch DW, Simonsen SE.Lim MY, et al.Haemophilia. 2024 Mar;30(2):470-477. doi: 10.1111/hae.14953. Epub 2024 Feb 11.Haemophilia. 2024.PMID:38343098
- von Willebrand Disease and other hereditary haemostatic factor deficiencies in women with a history of postpartum haemorrhage.Majluf-Cruz K, Anguiano-Robledo L, Calzada-Mendoza CC, Hernández-Juárez J, Moreno-Hernández M, Domínguez-Reyes VM, Figueroa-Torres AG, Gomez-Rosas P, Arreola-Diaz R, García-Lee MT, Ricardo-Moreno MT, Sosa-Camas RE, Garcia-Chavez J, Vela Ojeda J, Isordia-Salas I, Majluf-Cruz A.Majluf-Cruz K, et al.Haemophilia. 2020 Jan;26(1):97-105. doi: 10.1111/hae.13900. Epub 2019 Dec 11.Haemophilia. 2020.PMID:31823446
- Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.Batlle J, López-Fernández MF, Fraga EL, Trillo AR, Pérez-Rodríguez MA.Batlle J, et al.Blood Coagul Fibrinolysis. 2009 Mar;20(2):89-100. doi: 10.1097/MBC.0b013e3283254570.Blood Coagul Fibrinolysis. 2009.PMID:19786936Review.
- Von Willebrand Disease and Pregnancy: A Review of Evidence and Expert Opinion.Reynen E, James P.Reynen E, et al.Semin Thromb Hemost. 2016 Oct;42(7):717-723. doi: 10.1055/s-0036-1587686. Epub 2016 Sep 20.Semin Thromb Hemost. 2016.PMID:27648611Review.
Cited by
- ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.Connell NT, Flood VH, Brignardello-Petersen R, Abdul-Kadir R, Arapshian A, Couper S, Grow JM, Kouides P, Laffan M, Lavin M, Leebeek FWG, O'Brien SH, Ozelo MC, Tosetto A, Weyand AC, James PD, Kalot MA, Husainat N, Mustafa RA.Connell NT, et al.Blood Adv. 2021 Jan 12;5(1):301-325. doi: 10.1182/bloodadvances.2020003264.Blood Adv. 2021.PMID:33570647Free PMC article.
- The Effect of Von Willebrand Disease on Pregnancy, Delivery, and Postpartum Period: A Retrospective Observational Study.Sladič M, Verdenik I, Smrkolj Š.Sladič M, et al.Medicina (Kaunas). 2022 Jun 7;58(6):774. doi: 10.3390/medicina58060774.Medicina (Kaunas). 2022.PMID:35744037Free PMC article.
- Von Willebrand Disease Epidemiology, Burden of Illness and Management: A Systematic Review.Du P, Bergamasco A, Moride Y, Truong Berthoz F, Özen G, Tzivelekis S.Du P, et al.J Blood Med. 2023 Mar 2;14:189-208. doi: 10.2147/JBM.S389241. eCollection 2023.J Blood Med. 2023.PMID:36891166Free PMC article.Review.
- Correction: Postpartum Hemorrhage in Women with Von Willebrand Disease - A Retrospective Observational Study.Govorov I, Löfgren S, Chaireti R, Holmström M, Bremme K, Mints M.Govorov I, et al.PLoS One. 2017 Feb 9;12(2):e0172185. doi: 10.1371/journal.pone.0172185. eCollection 2017.PLoS One. 2017.PMID:28182756Free PMC article.
- Recombinant vs plasma-derived von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.Machin N, Ragni MV.Machin N, et al.Blood Adv. 2020 Jul 28;4(14):3234-3238. doi: 10.1182/bloodadvances.2020002046.Blood Adv. 2020.PMID:32692849Free PMC article.
References
- von Willebrand E. Hereditary pseudohaemophilia (historical annotation). Haemophilia. 1999;(5):223–31. - PubMed
- Lak M, Peyvandi F, Mannucci PM. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease. Br J Haematol. 2000;111(4):1236–9. . - PubMed
- Schneppenheim R, Budde U. Phenotypic and genotypic diagnosis of von Willebrand disease: a 2004 update. Semin Hematol. 2005;42(1):15–28. . - PubMed
- Biron C, Mahieu B, Rochette A, Capdevila X, Castex A, Amiral J, et al. Preoperative screening for von Willebrand disease type 1: low yield and limited ability to predict bleeding. The Journal of laboratory and clinical medicine. 1999;134(6):605–9. Epub 1999/12/14. . - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous